Cabometyx (cabozantinib) is a kinase inhibitor, a type of enzyme inhibitor that blocks the action of certain protein kinases.
Cabometyx is used to treat advanced kidney cancer, sometimes in combination with another medicine called nivolumab.
Cabometyx is also used to treat liver cancer (hepatocellular carcinoma) in people who have been previously treated with sorafenib.
